Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Stifel, Cytokinetics
Cytokinetics started at buy by Stifel, aficamten highlighted
Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming catalysts. Read more here.
Cytokinetics initiated with a Buy at Stifel
Stifel initiated coverage of Cytokinetics (CYTK) with a Buy rating and $80 price target Cytokinetics “is an out-of-favor stock” following the
Stifel Initiates Coverage of Cytokinetics (CYTK) with Buy Recommendation
Fintel reports that on January 22, 2025, Stifel initiated coverage of Cytokinetics (NasdaqGS:CYTK) with a Buy recommendation. Analyst Price Forecast Suggests 85.04% Upside As of December 23, 2024, the average one-year price target for Cytokinetics is $84.
Stifel starts Cytokinetics stock with Buy, $80 target
Stifel analysts initiated coverage on Cytokinetics shares (NASDAQ:CYTK), assigning a Buy rating and setting a price target of $80.00. The new coverage comes after a period of instability for the company,
Hosted on MSN
45m
Deregulation will help growth and tap down inflation, Stifel CEO says
Stifel CEO Ron Kruszewski discusses deregulation, economic growth, his expectations for the Federal Reserve handling of rates ...
2h
on MSN
Stifel maintains Buy on Revolve stock with $41 target
Stifel analysts kept a Buy rating on Revolve Group (NYSE:RVLV) shares, maintaining a $41.00 price target. The firm is ...
1d
Fastenal price target lowered to $82 from $86 at Stifel
Stifel lowered the firm’s price target on Fastenal (FAST) to $82 from $86 and keeps a Hold rating on the shares. Despite the ...
6d
Canada’s Eight Capital to Shut Down as Stifel Swoops In for Bankers
Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.
22h
Edgewise Therapeutics initiated with a Hold at Stifel
Stifel initiated coverage of Edgewise Therapeutics (EWTX) with a Hold rating and $30 price target The firm says that while Edgewise has “very ...
24/7 Wall St
23h
2025 Bull Market: Here's How High These Wall Street Analysts Think the Market Could Go In 2025
Wall Street analysts are buzzing with optimism as we step into 2025. There are plenty of reasons for a positive view to ...
5d
on MSN
Rapid7, Tenable cut to Hold at Stifel on low priority of vulnerability management
Stifel downgrades cybersecurity stocks Rapid7 and Tenable to Hold, citing cautious stance on vulnerability management.
Legal Sports Report
5d
Stifel Initiates FanDuel Parent Flutter With Buy Rating
Stifel initiated coverage of FanDuel parent company Flutter Thursday with a $320 target price and a buy rating.
12d
What Analysts Are Saying About Stifel Financial Stock
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...
Forbes
5d
Stifel Financial
Stifel Financial
Corp. provides securities brokerage, investment banking, trading, investment advisory and related financial services. It operates through the following segments: Global Wealth ...
6h
Edgewise rated as a new Hold at Stifel on a balanced risk-reward setup
Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Trade
NASDAQ
Cytokinetics
Edgewise Therapeutics
Procter & Gamble
Feedback